Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
dimanche, octobre 25
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Mangoceuticals Inc
MGRX
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$0.2318
-0.0125
-5.12%
Dern. MÀJ: Oct 23, 7:58 PM
Get Report
Aperçu
Actualités
Prévisions de résultats
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Mangoceuticals Financials
Mangoceuticals (MGRX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Stock Market Today: S&P 500, Dow Jones Futures Gain as Investors Await September's Jobs Report Data — NKE, SYNA, CTVA in Focus
U.S. stock futures advanced on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Thursday's higher close.
Rishabh Mishra
Nike, Synaptics And 3 Stocks To Watch Heading Into Friday
Nike falls on weak revenue; Synaptics jumps on $123 ON deal; AsiaStrategy surges on tokenization pact; Mangoceuticals drops.
Avi Kapoor
PRO
Mangoceuticals Q4 EPS $(0.13) Up From $(1.01) YoY, Sales $94.360K Down From $105.247K YoY
Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.13) per share. This is a 87.13 percent increase over losses of $(1.01) per share from the same period last year. The company reported $94.360 thousand in
Benzinga Newsdesk
Nasdaq Surges Over 1%; Lamb Weston Shares Decline Following Q2 Results
Avi Kapoor
PRO
Mangoceuticals Q2 EPS $(0.57) Up From $(1.35) YoY, Sales $168.109K Up From $163.163K YoY
Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.57) per share. This is a 57.78 percent increase over losses of $(1.35) per share from the same period last year. The company reported $168.109 thousand in
Benzinga Newsdesk
PRO
Mangoceuticals On Aug. 14 Reported Quarter Ended June 30 EPS $(0.09) Up From $(0.14) YoY; Revenue $163,163 Up From $141,237 YoY
Benzinga Newsdesk
